Parametric Portfolio Associates’s Acer Therapeutics Inc ACER Stock Holding History

Parametric Portfolio Associates’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,488	Closed	-$35K	–	3717
2021 Q3	$35K	Sell	13,488 -646	-5%	-$1.64K	﹤0.01%	3590
2021 Q2	$40K	Sell	14,134 -2,380	-14%	-$6.85K	﹤0.01%	3543
2021 Q1	$51K	Sell	16,514 -5,075	-24%	-$17.3K	﹤0.01%	4023
2020 Q4	$57K	Sell	21,589 -2,246	-9%	-$6.04K	﹤0.01%	3937
2020 Q3	$69K	Sell	23,835 -8,721	-27%	-$28.2K	﹤0.01%	3843
2020 Q2	$112K	Sell	32,556 -38,640	-54%	-$109K	﹤0.01%	3759
2020 Q1	$142K	Sell	71,196 -26,007	-27%	-$95.3K	﹤0.01%	3648
2019 Q4	$390K	Buy	97,203 +36,048	+59%	+$122K	﹤0.01%	3465
2019 Q3	$195K	Buy	+61,155	New	+$179K	﹤0.01%	3718

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Parametric Portfolio Associates's ACER Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Acer Therapeutics Inc (ACER) in Q4 2021, closing a stake of 13,488 shares — an estimated $35K sold.

Parametric Portfolio Associates first reported a position in ACER in Q3 2019 and held it in 9 quarters. The position peaked at $390K in Q4 2019. 24 funds tracked by Wall St. Rank hold ACER as of Q4 2021.

Parametric Portfolio Associates reported no remaining Acer Therapeutics Inc position as of Q4 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 13,488 Acer Therapeutics Inc shares in Q4 2021, an estimated $35K.
Parametric Portfolio Associates first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 9 quarters.
Parametric Portfolio Associates's Acer Therapeutics Inc position peaked at $390K in Q4 2019.
24 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.